LPL Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
99,889
-1,981
-2% -$31.6K ﹤0.01% 3853
2025
Q4
$1.65M Sell
101,870
-8,281
-8% -$135K ﹤0.01% 3572
2025
Q3
$1.65M Sell
110,151
-24,318
-18% -$296K ﹤0.01% 3496
2025
Q2
$1.57M Buy
134,469
+26,980
+25% +$245K ﹤0.01% 3349
2025
Q1
$799K Sell
107,489
-10,127
-9% -$77.8K ﹤0.01% 3747
2024
Q4
$705K Sell
117,616
-8,470
-7% -$46.7K ﹤0.01% 3789
2024
Q3
$646K Sell
126,086
-10,193
-7% -$44.4K ﹤0.01% 3781
2024
Q2
$493K Buy
136,279
+28,839
+27% +$91.5K ﹤0.01% 3886
2024
Q1
$345K Buy
107,440
+6,211
+6% +$24K ﹤0.01% 4094
2023
Q4
$496K Buy
101,229
+19,761
+24% +$90.2K ﹤0.01% 3674
2023
Q3
$444K Buy
81,468
+24,489
+43% +$162K ﹤0.01% 3585
2023
Q2
$382K Buy
56,979
+5,254
+10% +$39.1K ﹤0.01% 3669
2023
Q1
$457K Buy
51,725
+3,500
+7% +$30.9K ﹤0.01% 3408
2022
Q4
$368K Buy
48,225
+4,390
+10% +$34.2K ﹤0.01% 3511
2022
Q3
$312K Sell
43,835
-292
-0.7% -$2.75K ﹤0.01% 3547
2022
Q2
$357K Sell
44,127
-33,008
-43% -$290K ﹤0.01% 3479
2022
Q1
$1.07M Buy
77,135
+35,454
+85% +$557K ﹤0.01% 2557
2021
Q4
$1.17M Buy
41,681
+2,940
+8% +$90.1K ﹤0.01% 2524
2021
Q3
$1.32M Buy
38,741
+1,706
+5% +$61.7K ﹤0.01% 2396
2021
Q2
$1.51M Buy
37,035
+16,616
+81% +$646K ﹤0.01% 2202
2021
Q1
$822K Buy
20,419
+15,717
+334% +$851K ﹤0.01% 2574
2020
Q4
$278K Buy
+4,702
New +$242K ﹤0.01% 3263
2020
Q3
Sell
-19,352
Closed -$936K 3548
2020
Q2
$936K Buy
+19,352
New +$706K ﹤0.01% 1870
2020
Q1
Sell
-26,603
Closed -$796K 3207
2019
Q4
$796K Buy
+26,603
New +$764K ﹤0.01% 2009

Other funds holding ADPT